WOONSOCKET, R.I., March 15, 2018 /PRNewswire/ — CVS Health (NYSE: CVS) today released the following statement regarding the ”Patient Right to Know Drug Prices Act,” introduced by U.S. Senators Collins, McCaskill, Barrasso, Stabenow and Cassidy and the “Know the Lowest Price Act of…
|